| Home | E-Submission | Sitemap | Editorial Office
top_img
     
REVIEW
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Hepatocellular carcinoma (HCC) is a primary concern for patients with chronic hepatitis B (CHB). Antiviral therapy has been reasonably the focus of interest for HCC prevention, with most studies reporting on the role of the chronologically preceding agents, interferon-alfa and l...
ORIGINAL ARTICLE
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Background/Aims: This study aimed to clarify the effect of obesity on the development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients receiving antiviral treatment. Methods: This study applied a retrospective analysis to a historical cohort in Bundang Je...
ORIGINAL ARTICLE
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Background/Aims: To analyze the effects of preexisting lamivudine (LAM) resistance and applying antiviral treatment (adefovir [ADV] add-on LAM combination treatment) on long-term treatment outcomes, and comparing the clinical outcomes of antiviral-naïve chronic hepatitis B patie...
ORIGINAL ARTICLE
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
Background/Aims: The relationship between patient survival and biopsy-proven acute rejection (BPAR) in liver transplant recipients with hepatitis C remains unclear. The aims of this study were to compare the characteristics of patients with and without BPAR and to identify risk ...
ORIGINAL ARTICLE
Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
Background/Aims: Clear indicators for stopping antiviral therapy in chronic hepatitis B (CHB) patients are not yet available. Since the level of hepatitis B surface antigen (HBsAg) is correlated with covalently closed circular DNA, the HBsAg titer might be a good indicator of th...
Current Issue
Volume 22(3); Sep 2016
Volume 22(2); June 2016
Volume 22(1); March 2016
Volume 21(4); December 2015
Volume 21(3); September 2015
RSS feed
Reviews
309 Liver transplantation for advanced hepatocellular carcinoma
Hae Won Lee, Kyung-Suk Suh
Clin Mol Hepatol.2016;22(3):309-318.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0042
      
319 The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Ioannis Varbobitis, George V. Papatheodoridis
Clin Mol Hepatol.2016;22(3):319-326.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0045
      
327 Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen
Clin Mol Hepatol.2016;22(3):327-335.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0049
      
Editorial
336 Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
Byoung Kuk Jang
Clin Mol Hepatol.2016;22(3):336-338.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0104
      
Original Articles
339 Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park
Clin Mol Hepatol.2016;22(3):339-349.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0021
      
350 Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi
Clin Mol Hepatol.2016;22(3):350-358.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0019
      
359 Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong
Clin Mol Hepatol.2016;22(3):359-365.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0033
      
366 Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
Clin Mol Hepatol.2016;22(3):366-371.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0022
      
372 Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation
Ji Hye Jun, Jong Ho Choi, Si Hyun Bae, Seh Hoon Oh, Gi Jin Kim
Clin Mol Hepatol.2016;22(3):372-381.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0032
      
382 Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
Clin Mol Hepatol.2016;22(3):382-389.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0047
      
Case Reports
390 Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song
Clin Mol Hepatol.2016;22(3):390-395.   Published online 2016 August 30     
DOI: http://dx.doi.org/10.3350/cmh.2015.0050
                              
396 A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy
Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song
Clin Mol Hepatol.2016;22(3):396-399.   Published online 2016 August 30     
DOI: http://dx.doi.org/10.3350/cmh.2015.0039
                              
Liver Pathology
400 Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma
Kyoung-Bun Lee
Clin Mol Hepatol.2016;22(3):400-405.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0105
      
Liver Imaging
406 What we need to know when performing and interpreting US elastography
So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee
Clin Mol Hepatol.2016;22(3):406-414.   Published online 2016 September 25     
DOI: http://dx.doi.org/10.3350/cmh.2016.0106
      
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.